Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.42 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9239401 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| SCHEMBL15822354 | 0.88 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| SCHEMBL4745365 | 0.82 | CYP2A6 (0.48) | ALDH1A1SMN1; SMN2CYP2A6HSD17B10ALDH5A1 | |
| SCHEMBL173301 | 0.82 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| SCHEMBL8669516 | 0.80 | CYP2A6 (0.46) | ALDH1A1SMN1; SMN2CYP2A6HSD17B10ALDH5A1 | |
| SCHEMBL278055 | 0.80 | ALDH1A1 (0.58) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| SCHEMBL182937 | 0.80 | RAB9A (0.45) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| SCHEMBL10693711 | 0.79 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| Bromide SCHEMBL8645583 | 0.79 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 | |
| Phosphine SCHEMBL28908227 | 0.79 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2CYP3A4TP53ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119239161-A | Thin offset cold stamping material and preparation process thereof | 东莞光群雷射科技有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-114534707-B | Alkenyl benzene compound C=C isomerization catalyst and preparation method and application thereof | 中国科学院理化技术研究所 | 2024-03-01 | — | — | CN | claimed |
| CN-111217862-B | Preparation method of 4-aryl-6-ferrocenyl-3, 4-dihydropyrimidine-2 (1H) -ketone | 陕西科技大学 | 2023-01-31 | — | — | CN | claimed |
| CN-111217862-A | Preparation method of 4-aryl-6-ferrocenyl-3, 4-dihydropyrimidine-2 (1H) -ketone | 陕西科技大学 | 2020-06-02 | — | — | CN | claimed |
| EP-2970073-B1 | PRODUCTION OF PARA-PROPYLBENZALDEHYDE | ALBEMARLE CORP (US) | 2019-10-30 | — | — | EP | claimed |
| CN-105143166-B | Production of p-propylbenzaldehyde | 阿尔比马尔公司 | 2017-09-15 | — | — | CN | claimed |
| US-9567278-B2 | Production of para-propylbenzaldehyde | ALBEMARLE CORPORATION (US) | 2017-02-14 | — | — | US | claimed |
| EP-2970073-A2 | PRODUCTION OF PARA-PROPYLBENZALDEHYDE | Albemarle Corporation (US) | 2016-01-20 | — | — | EP | claimed |
| US-20150368175-A1 | PRODUCTION OF PARA-PROPYLBENZALDEHYDE | W.R. GRACE & CO.-CONN | 2015-12-24 | — | — | US | claimed |
| CN-105143166-A | Production of p-propylbenzaldehyde | ALBEMARLE CORP | 2015-12-09 | — | — | CN | claimed |
| WO-2007071743-A1 | IMPROVED PROCESS FOR THE PREPARATION OF THE SALTS OF 4-(BENZIMIDAZOLYLMETHYLAMINO)-BENZAMIDES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-06-28 | — | — | WO | claimed |
| US-20060287303-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2006-12-21 | — | — | US | claimed |
| WO-2006058294-A2 | MODULATORS OF MUSCARINIC RECEPTORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-06-01 | — | — | WO | claimed |
| US-7022862-B2 | Scalable synthesis of dipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2006-04-04 | — | — | US | claimed |
| US-20050038262-A1 | aldehyde-pyrrole catalytic condensation leading to dipyrromethanes as a crystalline solid or as intermediates used for making porphyrin compounds; non-aqueous process | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-02-17 | — | — | US | claimed |
| US-4868241-A | POLYVINYL ALCOHOL MODIFIED WITH BENZOIC ACID DERIVATIVE | AMERICAN CYANAMID COMPANY (US) | 1989-09-19 | — | — | US | claimed |
| EP-0231922-A2 | Electron beam and X-ray resists | AMERICAN CYANAMID COMPANY (US) | 1987-08-12 | — | — | EP | claimed |
| US-4619788-A | HEXASUBSTITUTED TRIBENZOCYCLONONATRIENE | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1986-10-28 | — | — | US | claimed |
| US-4582903-A | Synthesis of unsaturated hydantoins with an inexpensive catalyst | STAUFFER CHEMICAL COMPANY (US) | 1986-04-15 | — | — | US | claimed |
| US-4345072-A | Process for the production of 5-arylidene hydantoins (B) | DEGUSSA AG (DE) | 1982-08-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038262-A1 | aldehyde-pyrrole catalytic condensation leading to dipyrromethanes as a crystalline solid or as intermediates used for making porphyrin compounds; non-aqueous process | PPOX, DAO, DDO | ALDH1A1 72/4885SMN1; SMN2 4585/4885CYP3A4 257/4885 |
| US-20060287303-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | ALDH1A1 2356/4885SMN1; SMN2 3349/4885CYP3A4 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.